Related Experiment Video
Updated: Oct 25, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Recognized and Potentially New Biomarkers-Their Role in Diagnosis and Prognosis of Cardiovascular Disease
Weronika Bargieł1, Katarzyna Cierpiszewska1, Klara Maruszczak1
1Faculty of Medicine, Poznan University of Medical Sciences, 60-812 Poznan, Poland.
Insights
This review examines key atherosclerosis biomarkers, including hs-CRP, IL-6, Lp-PLA2, miRNA, osteocalcin, and angiogenin. Currently, no single biomarker can definitively assess atherosclerosis severity or predict cardiovascular risk.
Area of Science:
- Cardiovascular Research
- Biomarker Discovery
Background:
- Atherosclerosis is a primary global cause of mortality.
- Effective risk assessment and prognosis remain critical challenges in managing cardiovascular disease.
Purpose of the Study:
- To review and identify promising biomarkers for atherosclerosis.
- To evaluate biomarkers associated with inflammation, oxidative stress, and metabolism.
Main Methods:
- Literature review of atherosclerosis biomarkers.
- Focus on highly sensitive C-reactive protein (hs-CRP), interleukin 6 (IL-6), and lipoprotein-associated phospholipase A2 (Lp-PLA2).
- Inclusion of microRNA (miRNA), osteocalcin (OC), and angiogenin (ANG).
Main Results:
- Biomarkers related to inflammation and oxidative stress were analyzed.
- Metabolic and other novel biomarkers like miRNA and osteocalcin were assessed.
- Angiogenin was also considered in the context of atherosclerosis.
Conclusions:
- Atherosclerosis is a complex, multifactorial disease.
- No single biomarker currently exists for unambiguous assessment of atherosclerosis severity.
- Further research is needed for comprehensive cardiovascular risk prognostication.
Abstract:
Atherosclerosis and its consequences are the leading cause of mortality in the world. For this reason, we have reviewed atherosclerosis biomarkers and selected the most promising ones for review. We focused mainly on biomarkers related to inflammation and oxidative stress, such as the highly sensitive C-reactive protein (hs-CRP), interleukin 6 (IL-6), and lipoprotein-associated phospholipase A2 (Lp-PLA2). The microRNA (miRNA) and the usefulness of the bone mineralization, glucose, and lipid metabolism marker osteocalcin (OC) were also reviewed. The last biomarker we considered was angiogenin (ANG). Our review shows that due to the multifactorial nature of atherosclerosis, no single marker is known so far, the determination of which would unambiguously assess the severity of atherosclerosis and help without any doubt in the prognosis of cardiovascular risk.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Coronary Artery Disease I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

